The economic burden of COPD exacerbations.
Simoens
Steven
S
D000900:Anti-Bacterial Agents / Q000191:economics* / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000191:economics* / Q000627:therapeutic use; D017281:Cost of Illness; D005938:Glucocorticoids / Q000191:economics* / Q000627:therapeutic use; D017048:Health Care Costs; D006801:Humans; D009017:Morbidity / Q000639:trends; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy / Q000191:economics* / Q000453:epidemiology; D012008:Recurrence; D015996:Survival Rate / Q000639:trends
D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids